medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Note: This paper has not yet undergone formal peer review

Successful contact tracing systems for COVID-19
rely on effective quarantine and isolation
4 August 2020

A. James1,2* , M.J. Plank1,2 , S. Hendy2,3 , R. Binny2,4 , A. Lustig2,4 , N. Steyn2,3 , A Nesdale 5 , A Verrall6
1.
2.
3.
4.
5.
6.

School of Mathematics and Statistics, University of Canterbury, New Zealand
Te PÅ«naha Matatini, New Zealand.
Department of Physics, University of Auckland, New Zealand.
Manaaki Whenua, Lincoln, New Zealand.
Hutt Valley District Health Board, Lower Hutt, New Zealand.
Department of Pathology and Molecular Medicine, University of Otago, New Zealand.

*Corresponding author:
Email: alex.james@canterbury.ac.nz
Abstract
Background. Test, trace and isolate are the three crucial components of the response to COVID-19
identified by the World Health Organisation. Mathematical models of contact tracing often over-simplify
the ability of traced contacts to quarantine or isolate.
Method. We use an age-structured branching process model of individual disease transmission combined
with a detailed model of symptom onset, testing, contact quarantine and case isolation to model each aspect
of the test, trace, isolate strategy. We estimated the effective reproduction number under a range of scenarios
to understand the importance of each aspect of the system.
Findings. Peopleâ€™s ability to quarantine and isolate effectively is a crucial component of a successful
contact tracing system. 80% of cases need to be quarantined or isolated within 4 days of quarantine or
isolation of index case to be confident the contact tracing system is effective.
Interpretation. Provision of universal support systems to enable people to quarantine and isolate
effectively, coupled with investment in trained public health professionals to undertake contact tracing, are
crucial to success. We predict that a high-quality, rapid contact tracing system with strong support structures
in place, combined with moderate social distancing measures, is required to contain the spread of COVID19.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Evidence before this study. Existing models of contact tracing concentrate on the time taken to trace
contacts and the proportion of contacts who are traced, often focussing on the differences between manual
and digital tracing. They often over-simplify the quarantine and isolation aspect of contact tracing. For
example, some models assume that isolation and quarantine are 100% effective in preventing further
transmission, while others treat tracing coverage and isolation effectiveness as interchangeable. Numerous
performance indicators have been used to measure the effectiveness of a contact tracing system. However,
it is frequently not known how reliably these indicators measure the reduction in in onward transmission
under a range of unknown parameters.
Added value of this study. We explicitly model the effectiveness of contact quarantine and case isolation
in reducing onward transmission and show that these are not equivalent to tracing coverage. For example,
isolating 50% of contacts with 100% effectiveness gives a much larger reduction in onward transmission
than isolating all contacts but with only 50% effectiveness. We show that, although tracing speed is
important, without effective isolation and quarantine it is a waste of effort. We show that seemingly
straightforward indicators of contact tracing effectiveness are unreliable when the effectiveness of isolation
is not guaranteed. We propose an indicator based on the time between quarantine or isolation of an index
case and quarantine or isolation of secondary cases that is more robust to unknowns.
Implications of all the available evidence. Establishing support systems to enable individuals to
quarantine and isolate effectively is equally important as implementing a fast and efficient contact tracing
system. Effective contact tracing requires a skilled, professional workforce that can trace downstream
contacts of a positive case, as well as upstream contacts to determine the source of infection and provide
the high quality data needed. Over-reliance on digital contact tracing solutions or the use of untrained
contact tracing staff are likely to lead to less favourable outcomes.

1

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Introduction
The WHO guidelines for control of COVID-19 emphasise three crucial components of an effective strategy:
test, trace, and isolate 1 . Collectively, this system of rapid case and contact management has become one of
the key public health tools in the fight against COVID-19 worldwide 2-4 . Contact tracing has been crucial
in controlling several disease outbreaks, notably SARS, MERS and Ebola 5,6 . While contact tracing alone
is unlikely to contain the spread of COVID-19 7,8 , in countries like New Zealand, which is close to local
elimination of the virus 9 , it may allow population-wide social distancing measures to be relaxed. In
countries with more widespread epidemics, it can allow safe reopening. There is a need for robust ways to
measure and improve the effectiveness of contact tracing in reducing the spread of COVID-19. However,
the effective reproduction number, ğ‘… ğ‘’ğ‘“ğ‘“, is difficult to measure directly, is affected by numerous factors
including population-wide restrictions, and can typically only be inferred after a substantial time lag 10. We
therefore need reliable indicators for the effectiveness of contact tracing and other case-targeted
interventions 11 .
Existing mathematical models of contact tracing 7,8 focus almost exclusively on the time taken to trace
contacts and the proportion of contacts who are traced. Most models assume that isolation is 100% effective
in preventing further onward transmission from traced cases 2 . Other models assume the effectiveness of
isolation and the probability of being traced are interchangeable, i.e. a system where 50% of contacts are
traced and isolation is 100% effective is assumed to have the same outcomes as one where 100% of contacts
are traced and isolation reduces onward transmission by 50% 7 . Quarantine refers to the separation of
individuals who may have been exposed to the virus but are currently asymptomatic, and is distinct from
isolation of symptomatic or confirmed cases 12 . In reality, the quarantining of contacts and isolation of cases
are complex and depend on a range of variables. Complete isolation of all confirmed cases is impractical
in most countries: some contact with household members and essential service providers or healthcare
workers is inevitable in at least some cases. Barriers to effective isolation are higher in communities with
high levels of socioeconomic deprivation, insecure employment, and limited entitlement to paid sick leave.
Quarantine of asymptomatic case contacts, the majority of whom are likely not infected, is even more
challenging 13 . In countries with large outbreaks, this could affect tens of thousands of people and require
closure of entire workplaces for extended periods. As digital contact tracing systems are introduced, the
number of false positives could increase further. Taking time off work to quarantine when asymptomatic is
likely to be impossible for many. This suggests that quarantine is likely to involve precautionary measures
rather than complete isolation and therefore to be less effective than isolation of confirmed cases.
We explicitly model the effectiveness of contact quarantine and case isolation in reducing onward
transmission. We use a model calibrated using data on COVID-19 cases in New Zealand, where the virus
has been controlled effectively and the number of current cases is very low. We also evaluate four potential
performance indicators for the contact tracing system. We show that seemingly straightforward indicators,
such as the proportion of cases quarantined before symptom onset, can be misleading. We propose an
indicator based on the time between quarantine or isolation of an index case and quarantine or isolation of
secondary cases. This may be harder to measure than some indicators, but is a more reliable measure of the
reduction in the effective reproduction number. Our results highlight the importance of establishing support
systems to enable individuals to quarantine and isolate effectively14 . They also demonstrate that effective
contact tracing requires a skilled, professional workforce that can trace downstream contacts of a positive
case, as well as upstream contacts to determine the source of infection and provide the high quality data
needed. This implies that over-reliance on digital contact tracing solutions or the use of contact tracing staff
who are not trained in public health work are likely to lead to less favourable outcomes.

2

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 1. Schematic diagram of the contact tracing model. Infectious individuals are initially
asymptomatic (yellow). For the index case who was not traced (0), there is a delay between onset of
symptoms (red) and getting tested. Isolation occurs at some point between symptom onset and
testing. There is a subsequent delay to the test result and tracing of contacts. Traced contacts (1-4)
are quarantined when contacted by public health officials (phone icons) and isolated and tested
immediately on symptom onset. Traced contacts (3) who are already symptomatic prior to being
traced are isolated immediately when contacted. Traced contacts (4) that have already isolated prior
to being traced are not affected. Contacts that cannot be traced (5) may still get tested and isolated,
but this is likely to take longer. Asymptomatic individuals (1) do not get tested or isolated, but will
be quarantined if they are a traced contact.

3

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Transmission, contact tracing, quarantine and isolation model
We use a continuous-time branching process model 15 to study the transmission of COVID-19 in the
presence of contact tracing and case isolation (Figure 1) â€“ see Supplementary Materials for details.
Individual infectiousness is modelled using a time-dependent infection kernel connected with the time of
symptom onset, with 35% of infections assumed to occur prior to onset 16,17 . The key input parameters for
the contact tracing model are: (i) the proportion of contacts successfully traced; (ii) the mean time taken to
trace contacts following a positive test result in the index case; and (iii) the effectiveness of contact
quarantine and case isolation in reducing onward transmission. The time for tracing ranges from zero, which
can usually only be achieved for household contacts or by using a highly effective digital tracing system,
through to 6 days on average. Traced contacts of a positive case who are not currently symptomatic go into
home quarantine, i.e. minimise their interactions with others. Upon symptom onset, traced contacts isolated
more stringently and tested for SARS-CoV-2. We assume that untraced symptomatic cases are also tested
and isolated, but there is a delay from onset to isolation and testing (see Supplementary Materials for
distributions). The model is based on New Zealand data which has a fast testing system with only one day
on average between testing (when isolation starts) and result (when tracing starts). However, the shape of
the assumed distribution for tracing time means the model can still be applied to countries where testing is
slower by increasing the mean time from testing of the index case to tracing of contacts.
Measuring the input parameters empirically is not straightforward. In many countries, quarantine and
isolation are left to the individual. Without strong government and community support, quarantine of
asymptomatic or presymptomatic individuals in particular may be ineffective. Measuring the reduction in
the number of onward transmissions during quarantine and isolation relies on high-quality data to compare
contact rates of similar individuals across a broad sector of society. Even quantifying the proportion of
contacts traced is not always straightforward due to imperfect recall.

4

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 2: The effectiveness of a contact tracing and isolation system is strongly affected by the
proportion of contacts trace d, the tracing speed and the effectiveness of quarantine and
isolation. Effectiveness measured by the reduction in effective reproduction number ğ‘…ğ‘’ğ‘“ğ‘“ relative to
the no-control scenario against the expected number of days to trace contacts for a range of tracing
probabilities and quarantine/isolation effectiveness.

Determinants of the effectiveness of contact tracing
We run the model for three tracing probabilities, 0% (no contact tracing), 50% and 100% (all contacts
traced), and a range of tracing speeds from instant tracing to 6 days on average. The reduction in onward
transmission as a result of quarantine or isolation ranges from 50% to 100%. We assume that case isolation
is always at least as effective as quarantine of asymptomatic contacts.
It is possible to have a case isolation policy with no contact tracing (Fig. 2, red lines). In this case, the more
effective isolation is, the larger the decrease in ğ‘…ğ‘’ğ‘“ğ‘“ (compare Fig 2A, D, F, red lines). Across all isolation
and quarantine scenarios, slow tracing results in poorer outcomes than fast tracing, i.e. higher ğ‘…ğ‘’ğ‘“ğ‘“ (Figure
2). If tracing is fast, then tracing more contacts reduces ğ‘…ğ‘’ğ‘“ğ‘“ further; if tracing is very slow (more than 5
days on average), the system is ineffective regardless of the proportion of contacts traced and the reduction
in ğ‘…ğ‘’ğ‘“ğ‘“ is similar to the no-tracing or isolation only scenario.
In the results shown in Figure 2, we fixed the average time from testing to the test result being returned and
varied the average time from a positive test result to being returned to tracing contacts. The key factor is
5

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

the total delay from testing the index case to tracing contacts and the model is relatively insensitive to the
breakdown of this total delay between testing and tracing. For example an average testing time of 1 day and
an average tracing time of 5 days produces similar results to an average testing time of 3 days and an
average tracing time of 3 days.
In reality, tracing speed and proportion of contacts traced may be linked: tracing a few contacts, particularly
household or other close contacts, can be done quickly; but tracing a high proportion of all contacts will
include contacts who are harder to trace, so the mean tracing time will increase. Our results show if the
average tracing time is more than 6 days, there is little benefit trying to trace more contacts in terms of a
reduction in ğ‘… ğ‘’ğ‘“ğ‘“ and the priority should be faster tracing.
The effectiveness of quarantine and isolation is a crucial determinant of the ability of the contact tracing
system to reduce ğ‘… ğ‘’ğ‘“ğ‘“. Because there is significant pre-symptomatic transmission of COVID-19 16,17 , fast
tracing in conjunction with effective quarantine of contacts before symptom onset can greatly reduce
spread. Although some countries, notably China, established arrangements for institutional isolation and
monitored quarantine 18 , most countries in Europe, North America and Australasia rely on home quarantine
for contacts and home isolation for mild cases. Asking individuals to quarantine or isolate but failing to
support them to do so means, for example, they will need to go shopping for food and other essential items,
or have them delivered by family or friends who potentially should also be in isolation. Many individua ls
may be ineligible for paid sick leave, especially when asymptomatic. Crowded or unsuitable housing may
mean isolation is not feasible. Precarious employment situations could be exacerbated by prolonged and
possibly repeated absences. Given these realities, it is unlikely that 100% effective isolation and quarantine
(Fig. 2A) is achievable. A more realistic scenario is where quarantine only reduces onward transmission by
50% (Fig. 2C). If tracing is instantaneous, this provides the same reduction in ğ‘… ğ‘’ğ‘“ğ‘“ as a mean tracing time
of 2â€“3 days with 100% effective quarantine. If isolation of cases is only 50% effective (Fig. 2F), improving
isolation may be more impactful than faster or more complete contact tracing (Fig. 2A, red line). Tracing
50% of contacts with 100% quarantine and isolation effectiveness (Fig 2A, blue line) is significantly more
effective than tracing 100% of contacts with 50% isolation and quarantine effectiveness (Fig 2F, green
line), whereas previous models 7 could not distinguish these two scenarios.

6

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 3: The proportion of cases quarantined or isolated within 4 days of the index case being
quarantined or isolated (A) is the most robust indicator of the performance of the contact tracing
system, measured by the reduction in effective reproduction number ğ‘¹ğ’†ğ’‡ğ’‡ relative to the no control
case. Other indicators are not reliably correlated with ğ‘…ğ‘’ğ‘“ğ‘“ across all model parameters. Each plotted point
corresponds to one combination of model parameters: fast tracing (same time as test result) of 50% of
contacts (stars); fast tracing of 100% of contacts (crosses); slow tracing (on average 3 days after test result)
of 50% of contacts (circles); slow tracing of 100% of contacts (pluses); varying effectiveness of isolation
and quarantine are shown by different colours (see graph legend). Vertical dashed lines show the minimum
and maximum values of the indicators computed from New Zealand case data.

Measuring the effectiveness of contact tracing
The key output of interest is the effective reproduction number ğ‘… ğ‘’ğ‘“ğ‘“, defined in the model as the average
number of secondary infections per case. It is difficult to measure ğ‘…ğ‘’ğ‘“ğ‘“ directly in practice because not all
cases are detected and it is not always possible to link secondary cases with a unique index case. In addition,
it is difficult to obtain reliable data to quantify the input parameters for the contact tracing model. The
average tracing time is the easiest input parameter to measure, although this could be underestimated if
some contacts present to healthcare before being traced. Officially reported values for the proportion of
contacts traced typically represent the proportion of known contacts and do not include contacts that were
not recalled by the case. Directly measuring the effectiveness of quarantine and isolation would require
detailed information about the number of secondary infections during these periods. This would require
intensive follow-up with quarantined and isolated individuals. Unless this was done for all cases, this
intervention itself could bias the sample towards individuals with relatively effective isolation.

7

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

A robust performance indicator should: (i) be measurable from data routinely collected by public health
organisations; and (ii) be closely correlated with the effective reproduction number ğ‘…ğ‘’ğ‘“ğ‘“ across a broad
range of model inputs. In the absence of direct information about input parameters, we assessed the
following potential performance indicators for the case isolation and contact tracing system 11 :
ï‚·
ï‚·
ï‚·
ï‚·

Proportion of cases quarantined or isolated within 4 days of symptom onset in the index case.
Proportion of cases quarantined or isolated within 4 days of quarantine or isolation of the index
case.
Proportion of cases with symptom onset within 4 days of symptom onset in the index case (i.e.
serial interval less than 4 days).
Proportion of cases quarantined before symptom onset.

The most robust indicator tested was the proportion of cases that were quarantined or isolated within 4 days
of quarantine or isolation of the index case (Fig. 3A). This indicator is well correlated with ğ‘…ğ‘’ğ‘“ğ‘“ across
variations in all three input parameters, meaning that improvements in contact tracing parameters are
reliably associated with improvements in the indicator. In contrast, indicators that use onset time can be
misleading. For example, the proportion of cases quarantined within 4 days of onset in the index case (Fig.
3B) depends almost exclusively on tracing speed and proportion of contacts traced, and is insensitive to the
effectiveness of quarantine or isolation. If the effectiveness of quarantine and case isolation can be evaluated
independently or assured in some other way, this could be a useful indicator of system effectiveness, but
without this it is not useful. The serial interval (Fig. 3C) is determined predominantly by the virus
transmission dynamics, in particular the incubation period. The effectiveness of quarantine has the strongest
effect on this indicator by preventing onward transmission late in the infectious phase, but an improvement
in either the tracing speed or the proportion of contacts traced leads to an apparent deterioration in the
indicator. The reason for this counterintuitive result is that, as the contact tracing system becomes more
effective in reducing transmission, the remaining cases contain a higher proportion of cases who were
infected by subclinical carriers. These cases cannot be traced in the model and so continue to spread the
virus relatively late in their infectious periods, leading to longer serial intervals.
The proportion of cases quarantined before symptom onset is the easiest indicator to measure as it can be
calculated for all cases, including those that are not associated with a specific index case. However, it is the
worst of the four indicators tested, showing apparently poorer outcomes as the effectiveness of quarantine
or isolation improves (Fig. 3D). This happens because effective case-targeted interventions tend to prevent
secondary infections that occur late in the infectious phase (e.g. case 2 in Fig. 1). The remaining cases are
skewed towards those that were infected early in the infectious phase of the index case (e.g. case 3 in Fig.
1). These cases are the hardest to trace before symptom onset.

Benchmarking against the New Zealand contact tracing system
We used the New Zealand EpiSurv dataset, centrally managed by ESR on behalf of the Ministry of Health
(accessed 2 June 2020). We included the ğ‘ = 95 cases with no recent history of overseas travel and with
a symptom onset date between 8 April and 8 May. This minimises the impact of changes that may have
occurred as a result of expansion of the contact tracing system at the start of the epidemic, and reduced
contact rates following the introduction of strict social distancing restrictions on 26 March. Case discovery
is categorised as either â€œcontact of a caseâ€ (ğ‘ = 82), â€œsought healthcareâ€ (ğ‘ = 9) or other. Of the 82 cases
labelled as â€œcontact of a caseâ€, all were associated with at least one index case, allowing the values of the
first three performance indicators defined above to be empirically calculated (see Supplementary Materials
8

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

for details). The final indicator, proportion of contacts quarantined before symptom onset was calculated
for all cases with available data.
Defining traced contacts to be the 82 cases labelled as â€œcontact of a caseâ€ implies a tracing rate of 86%. Of
these cases, 56% were quarantined or isolated prior to symptom onset. There was almost no difference in
the average time from onset to testing between the traced and non-traced contacts (mean 2.8 days, standard
deviation 2.6 days for non-contacts; mean 3.1 days, standard deviation 2.5 days for contacts). This suggests
that many of the cases labelled as â€œcontact of a caseâ€ may have self-identified or been identified post hoc,
as opposed to being traced by public health officials. This reinforces the view that directly quantifying the
proportion of contacts who are traced is difficult and that this may not be accurately reflected in routinely
collected public health data.
To evaluate the effectiveness of the New Zealand contact tracing system, we calculated each of the four
performance indicators across all cases in the sample (Fig. 3, vertical dashed lines). New Zealand Public
Health Units have considerable contact tracing experience through routine management of tuberculosis
cases, as well as previous epidemic outbreaks including measles and pandemic H1N1 influenza. Contact
tracing staff have a background in public health and experience of managing the privacy issues that are
involved in the work. Extensive interviews with cases establish potential source cases and identify contacts.
Contacts are regularly monitored, often daily, to ensure adherence to quarantine restrictions, fast testing
and an accurate onset time if symptoms develop. Quarantine and isolation are supported through workplace
support and family care, and limited community quarantine or isolation facilities are available for those
whose homes are unsuitable. The COVID-19 response was supplemented by a rapidly developed national
contact management service to augment the scalability of local services and address fragmented information
systems 11 . A significant proportion of cases in New Zealand were associated with long-haul international
travel, and tended to occur in relatively healthy, high socio-economic groups who were in a position to
adhere to the restrictions. There were also cases in communities where financial and job insecurities were
a significant issue. In addition, the data spans a period during which New Zealand was under the strictest
social distancing measures, reducing contacts significantly 19 . With no knowledge of the other system
parameters using the recommended indicator (Fig. 3A) suggests that the contact tracing system reduced
ğ‘…ğ‘’ğ‘“ğ‘“ by 30â€“45% during this period. The noise in the data from self-reporting of isolation and symptom
onset dates and the uncertainty in assigning index cases does not allow for a more accurate estimate. For
comparison the indicator in Fig 3B, the proportion of cases where index onset to case quarantine is less
than four days gives a much wider prediction of 20% to 45% ğ‘… ğ¸ğ‘“ğ‘“ reduction.

Discussion and conclusions
Our results show that a high-quality, rapid contact tracing system, combined with strong support systems
for people in quarantine or isolation, can reduce the effective reproduction number ğ‘…ğ‘’ğ‘“ğ‘“ by at most 60%.
In the absence of any control interventions, the basic reproduction number ğ‘…0 for COVID-19 is estimated
to be between 2 and 4 20-22 . Containing the spread of COVID-19 requires ğ‘…ğ‘’ğ‘“ğ‘“ < 1, which implies that
some level of moderate social distancing will likely be required during outbreaks in addition to casetargeted interventions. If case isolation or contact quarantine are imperfect, or some contacts are not traced
or traced more slowly, then the reduction in ğ‘…ğ‘’ğ‘“ğ‘“ is only around 40%, meaning that stronger social
distancing would be required to contain future outbreaks. In a country where testing is very slow, for
example if it takes more than five days to return test results, it may be more effective to concentrate on
highly effective isolation rather than contact tracing. Our model assumed that all clinical cases were
diagnosed, which relies on widespread availability and uptake of testing. Case-targeted measures will be
less effective if there is significant case under ascertainment.
9

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

We recommend using the time from quarantine or isolation of the index case to quarantine or isolation of
secondary cases as the basis for measuring the performance of the contact tracing system. If at least 80%
of cases are quarantined or isolated within 4 days of quarantining or isolating the index case, this indicates
a reduction in ğ‘…ğ‘’ğ‘“ğ‘“ of at least 40%. For this to be effective, it has been suggested that the definition of a
contact should be within 2 metres of an infected case for 15 minutes or more 23 .
Oâ€™Dowd 24 and Verrall 11 identified key criteria against which to evaluate the contact tracing system, for
example, suggesting that at least 80% of contacts must be quarantined within 4 days of symptom onset in
the index case. We have shown that if the effectiveness of quarantine and isolation can be guaranteed, this
criteria can be useful to benchmark a system. However, when these are not accurately known, the indicator
recommended above is more robust. Case-targeted interventions tend to prevent onward transmission late
in the infectious period. This skews remaining cases towards those infected in the pre-symptomatic or early
symptomatic phase of the index case, and these are more difficult to trace in a timely way. Our work shows
that in order to establish the effectiveness of a system, index-case pairs must be determined as accurately
as possible, even if this is done post hoc with case investigation. Without this information, there is a danger
that seemingly simple criteria, such as the proportion of cases quarantined before symptom onset, could
give misleading indications of system performance.
The New Zealand contact tracing system is well-established and run by highly trained public health staff.
Their work has been critical to the success of New Zealandâ€™s elimination strategy for COVID-19 9.
However, even this well-established system suffers from noisy data and the difficulties of establishing
index-case pairs. Our results show that even this success story can be improved, and, more usefully, point
to the areas that need the most attention, in this case reducing the time taken to trace contacts. For countries
with large outbreaks where contact tracing is either not well-established or does not have sufficient capacity
to deal new daily cases, our results show that improving the effectiveness of case isolation may be better
strategy initially.
Our model assumed that, in the absence of any case-targeted interventions, 35% of infections are subclinical
with transmission rates reduced by 50% 25 and 35% of all onward transmission occurs during the presymptomatic phase. There is a wide range in empirically derived estimates for these parameters for COVID19 2,16,17,26,27 , and the effectiveness of contact tracing is sensitive to these 7 . If the true rates of asymptomatic
and pre-symptomatic transmission are less than these assumed values, contact tracing will be more effective
than our results predict. However, if the true values are higher, it is likely that contact tracing will need to
be combined with stronger social distancing measures to contain COVID-19. In any case, the conclusion
remains that the provision of systems to support people to quarantine and isolate effectively and the ability
to rapidly trace the majority of contacts are crucially important. Our model does not distinguish between
the different types of contact, such as household, work or casual, and each of these groups may have
different tracing speeds and isolation effectiveness. This would be a useful addition to the model but would
not undermine the conclusions on isolation effectiveness and robust indicators.
Further investment in improving the speed and capacity of contact tracing systems is needed. This is likely
to be much more cost-effective than having to prolong or return to strict population-wide social distancing
measures to contain a resurgence in cases. The crucial importance of support systems for people in
quarantine or isolation and the ability to rapidly trace the majority of contacts mean that investment in
skilled professionals and workers trained in public health work is essential. Overreliance on digital or
automated contact tracing solutions or outsourcing case interviews and follow-up to undertrained staff are
likely to substantially compromise these aspects of the system. Experience from the New Zealand contact
tracing effort shows that the development of trusted relationships by public health officials and local
community representatives is critical to an effective system. The success of contact tracing also relies on

10

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

the universal provision of social security such as paid sick leave, leave entitlements for asymptomatic
individuals in quarantine, and adequate job security and unemployment benefits.

11

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

References
1.
World Health Organization. Contact tracing in the context of COVID-19: interim guidance, 10 May
2020, 2020.
2.
Ferretti L, Wymant C, Kendall M, et al. Quantifying SARS-CoV-2 transmission suggests epidemic
control with digital contact tracing. Science 2020; 368(6491).
3.
Ienca M, Vayena E. On the responsible use of digital data to tackle the COVID-19 pandemic. Nature
medicine 2020; 26(4): 463-4.
4.
Sun K, Viboud C. Impact of contact tracing on SARS-CoV-2 transmission. The Lancet Infectious
Diseases 2020.
5.
World Health Organization Centers for Disease Control Prevention. Implementation and
management of contact tracing for Ebola virus disease: emergency guideline: World Health Organization,
2015.
6.
Kang M, Song T, Zhong H, et al. Contact tracing for imported case of Middle East respiratory
syndrome, China, 2015. Emerging infectious diseases 2016; 22(9): 1644.
7.
Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of
cases and contacts. The Lancet Global Health 2020.
8.
Kucharski AJ, Klepac P, Conlan A, et al. Effectiveness of isolation, testing, contact tracing and
physical distancing on reducing transmission of SARS-CoV-2 in different settings. medRxiv 2020.
9.
Cousins S. New Zealand eliminates COVID-19. The Lancet 2020; 395(10235): 1474.
10.
Obadia T, Haneef R, BoÃ«lle P-Y. The R0 package: a toolbox to estimate reproduction numbers for
epidemic outbreaks. BMC medical informatics and decision making 2012; 12(1): 147.
11.
Verrall A. Rapid Audit of Contact Tracing for Covid-19 in New Zealand. Ministry of Health 2020.
12.
World Health Organization. Considerations for quarantine of individuals in the context of
containment for coronavirus disease (COVID-19): interim guidance, 19 March 2020: World Health
Organization, 2020.
13.
European Centre for Disease Prevention and Control. Contact tracing: Public health management
of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union
- second update. Stockholm: ECDC, 2020.
14.
Centre for Disease Control. Self-Isolation and Self-Quarantine Home Assessment Checklist for
Coronavirus Dusease 2019 (COVID-19), 2020.
15.
James A, Plank MJ, Binny RN, et al. A structured model for COVID-19 spread: modelling age and
healthcare inequities. medRxiv 2020.
16.
Ganyani T, Kremer C, Chen D, et al. Estimating the generation interval for coronavirus disease
(COVID-19) based on symptom onset data, March 2020. Eurosurveillance 2020; 25(17): 2000257.
17.
Tindale L, Coombe M, Stockdale JE, et al. Transmission interval estimates suggest presymptomatic spread of COVID-19. MedRxiv 2020.
18.
Chen S, Zhang Z, Yang J, et al. Fangcang shelter hospitals: a novel concept for responding to public
health emergencies. The Lancet 2020.
19.
Binny RN, Hendy SC, James A, Lustig A, Plank MJ, Steyn N. Effect of Alert Level 4 on effective
reproduction number: review of international COVID-19 cases. medRxiv 2020.
20.
Liu Y, Gayle AA, Wilder-Smith A, RocklÃ¶v J. The reproductive number of COVID-19 is higher
compared to SARS coronavirus. Journal of travel medicine 2020.
21.
Flaxman S, Mishra S, Gandy A, et al. Report 13: Estimating the number of infections and the impact
of non-pharmaceutical interventions on COVID-19 in 11 European countries. 2020.
22.
Jarvis CI, Van Zandvoort K, Gimma A, et al. Quantifying the impact of physical distance measures
on the transmission of COVID-19 in the UK. BMC medicine 2020; 18: 1-10.

12

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

23.
Keeling MJ, Hollingsworth TD, Read JM. The Efficacy of Contact Tracing for the Containment of
the 2019 Novel Coronavirus (COVID-19). medRxiv 2020.
24.
Oâ€™Dowd A. Covid-19: Johnson is on back foot over next steps to control pandemic. British Medical
Journal 2020; 369.
25.
Chau NVV, Lam VT, Dung NT, et al. The natural history and transmission potential of asymptomatic
SARS-CoV-2 infection. medRxiv 2020.
26.
Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population.
New England Journal of Medicine 2020.
27.
Lavezzo E, Franchin E, Ciavarella C, et al. Suppression of COVID-19 outbreak in the municipality of
Vo, Italy. medRxiv 2020.
28.
Nishiura H, Linton NM, Akhmetzhanov AR. Serial interval of novel coronavirus (COVID-19)
infections. International journal of infectious diseases 2020.
29.
Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their
close contacts in Shenzhen, China: a retrospective cohort study. The Lancet Infectious Diseases 2020.
30.
Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, Group CC-W. The effect of nonpharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a
modelling study. MedRxiv 2020.
31.
Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual
variation on disease emergence. Nature 2005; 438(7066): 355-9.
32.
Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys
and demographic data. PLoS computational biology 2017; 13(9): e1005697.
33.
Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19)
from publicly reported confirmed cases: estimation and application. Annals of internal medicine 2020;
172(9): 577-82.
34.
Compass Research Centre. International Social Survey Programme (ISSP) 2017: Social Networks New Zealand Survey. Auckland, New Zealand: University of Auckland; 2018.

13

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Acknowledgements
The authors acknowledge the support of StatsNZ, ESR, the Ministry of Health and Barry Milne (Compass
Research Centre, University of Auckland) in supplying data in support of this work. This work was funded
by the Ministry of Business, Innovation and Employment, New Zealand and Te PÅ«naha Matatini, the NZ
Centre of Research Excellence for Complex Systems.
Author contributions
AJ, MP developed the initial idea, and designed the methodology, AJ applied the model, NS, RB, AL
curated data, SH provided project administration, All authors contributed to writing, review and editing.
Competing interests
This paper was written in Dr Verrall's capacity as Senior Lecturer at the University of Otago, not in her
capacity as a candidate for Parliament. The views in this paper are not necessarily the views of the New
Zealand Labour Party. All other authors declare no competing interests.
Data availability
For privacy reasons data is not publicly available. Please contact the authors or the New Zealand Ministry
of Health to discuss availability for research purposes.

14

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Supplementary Materials
Successful contact tracing systems for COVID-19 rely on effective quarantine and isolation
A. James, M.J. Plank, S. Hendy, R. Binny, A. Lustig, N. Steyn, A. Nesdale, A. Verrall
Corresponding author: alex.james@canterbury.ac.nz

Contents
Materials and Methods: Model
Figure S1: Model generation time distribution.
Table S1: Parameter values and their sources.

15

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Materials and Methods: Model

We use an age-structured continuous-time branching process model
COVID-19 in the presence of contact tracing and case isolation.

15

to study the transmission of

Model assumptions. The key assumptions of the model are:
ï‚·

ï‚·

ï‚·

ï‚·

ï‚·

ï‚·
ï‚·

Infected individuals fall into one of two categories: clinical or subclinical. Subclinical infections
are assumed to have a reduced infectiousness (see Table S1 for parameter values). Note that
subclinical individuals are asymptomatic during the entire infectious period and therefore are
unlikely to be detected. Individuals who are pre-symptomatic are included in the clinical
category.
For clinical infections, the time between exposure and onset of symptoms (in days) ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ is
drawn from a gamma distribution
ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ ~ Î“(5.8, 0.95).
The times of secondary infections ğ‘‡ğ‘  are drawn from an individual-specific generation time
distribution, which is shifted according to the onset time ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ of the index case 7 via:
ğ‘‡ğ‘  âˆ’ ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ + ğ‘¡ğ‘ ~ ğ‘Šğ‘’ğ‘–ğ‘ğ‘¢ğ‘™ğ‘™(5.67,2.83)
where ğ‘¡ğ‘ > 0 is a constant chosen so that ğ‘ğ‘ğ‘Ÿğ‘’ = 35% of secondary infections occur prior to
onset. Allowing for pre-symptomatic transmission in this way is realistic, but introduces the
possibility that secondary infections could occur before infection of the index case. To prevent
this, any randomly generated secondary infection times with ğ‘‡ğ‘  < ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ are discarded and
another secondary infection time is generated instead. The population-wide generation time
distribution is a model output (see Figure S1) and is consistent with empirical estimates 2,28,29 .
Symptomatic individuals who are not traced self-isolate after symptom onset. The time
between symptom onset and isolation, ğ‘‡ğ‘–ğ‘ ğ‘œ , is Gamma distributed
ğ‘‡ğ‘–ğ‘ ğ‘œ ~Î“(0.62, 3.47).
The distribution is found by fitting to the time between symptom onset and isolation in the NZ
case data including all untraced individuals without a recent overseas arrival history and onset
date between 8 th April and 8 th May.
All clinical cases get tested. i.e. ğ‘ğ‘¡ğ‘’ğ‘ ğ‘¡ = 1. In the absence of any contact tracing, the time, in
days, between symptom onset and testing, ğ‘‡ğ‘¡ğ‘’ğ‘ ğ‘¡ is Gamma distributed
ğ‘‡ğ‘¡ğ‘’ğ‘ ğ‘¡ ~Î“(1.22, 2.17).
The distribution is found by fitting to the time between symptom onset and test date of the
NZ case data of all untraced individuals without a recent overseas arrival history and onset
date between 8 th April and 8 th May.
Isolation reduces infectiousness to ğ‘ğ‘–ğ‘ ğ‘œ of initial infectiousness; this is assumed to take effect
from either the isolation date or the test date, whichever is earlier.
The time from testing to test result, ğ‘‡ğ‘Ÿğ‘’ğ‘ ğ‘¢ğ‘™ğ‘¡, (in days) is a minimum period plus an exponentially
distributed random variable:
ğ‘‡ğ‘Ÿğ‘’ğ‘ ğ‘¢ğ‘™ğ‘¡ âˆ’ 0.5 ~ ğ¸ğ‘¥ğ‘(0.5)
This is an approximate match to the New Zealand data.
16

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

ï‚·

ï‚·

ï‚·

ï‚·

ï‚·
ï‚·
ï‚·
ï‚·

A positive test result initiates tracing of the index caseâ€™s contacts. It is assumed a proportion
ğ‘ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’ of contacts are successfully traced, though cases may be symptomatic, have isolated and
even been tested by the time they are traced.
The time between the index caseâ€™s test result and tracing of contacts, ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’, is Gamma
distributed with variance equal to 10% of the mean, i.e. tracing may be delayed but is completed
quickly.
Contacts traced before symptom onset go into partial isolation or quarantine, which reduces
infectiousness to ğ‘ğ‘ğ‘¢ğ‘ğ‘Ÿ of initial infectiousness. This is a weaker form of isolation during the
pre-symptomatic stage (ğ‘ğ‘ğ‘¢ğ‘ğ‘Ÿ â‰¥ ğ‘ğ‘–ğ‘ ğ‘œ ).
Once a traced contact develops symptoms, they are tested and fully isolated (infectiousness
ğ‘ğ‘–ğ‘ ğ‘œ) immediately (i.e. there is no delay from onset to testing or isolation). After the test -toresult delay described above, a positive test result initiates tracing of the secondary caseâ€™s
contacts.
Contacts traced after symptom onset immediately go into isolation and are tested.
Subclinical individuals do not develop symptoms, do not get tested or isolated and their
contacts are not traced.
Subclinical individuals can be traced contacts of an index case and be quarantined. However,
they do not develop symptoms and so will not get tested or fully isolated.
If isolation is not 100% effective tracing continues during isolation and contacts are still traced
with probability ğ‘ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’.

Stochastic branching process model. The stochastic model for transmission of the virus is as follows:
ï‚·
ï‚·
ï‚·
ï‚·
ï‚·

ï‚·

ï‚·

We segment the population into 3 age groups: 0-19 years, 19-65 years, over 65. The population
is assumed to be well mixed within each group.
The average reproduction number ğ‘… ğºğ‘ ğ‘¢ğ‘ of subclinical individuals in any group ğº was assumed
to be 50% of the average reproduction number ğ‘…ğºğ‘ğ‘™ğ‘–ğ‘› of clinical individuals in that group 30 .
In the absence of case isolation measures, each infected individual ğ‘– causes a randomly
generated number ğ‘ğ‘– ~ğ‘ƒğ‘œğ‘–ğ‘ ğ‘ ğ‘œğ‘›(ğ‘…ğ‘– ) of new infections.
We assume a moderate level of social distancing which reduces transmission rates to 70%.
As well as population heterogeneity across the different groups, individual heterogeneity in
transmission rates was included by setting ğ‘…ğ‘– = ğ‘… ğºğ‘ğ‘™ğ‘–ğ‘› ğ‘Œğ‘– for clinical individuals in group ğº and
ğ‘… ğ‘– = ğ‘…ğºğ‘ ğ‘¢ğ‘ğ‘Œğ‘– for subclinical individuals in group ğº, where ğ‘Œğ‘– is a gamma distributed random
variable with mean 1 and variance 2 31 .
All individuals are assumed to be no longer infectious 30 days after being infected. This is an
upper limit for computational convenience; in practice, individuals have very low
infectiousness after about 14 days after symptom onset because of the shape of the generation
time distribution (Fig. 1).
The model is simulated using a time step of ğ›¿ğ‘¡ = 0.5 days. At each step, infectious individual ğ‘–
produces a Poisson distributed number of secondary infections with mean
ğ‘¡+ğ›¿ğ‘¡
ğœ†ğ‘– = ğ‘…ğ‘–ğ¹(ğ‘¡, ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’,ğ‘– , ğ‘‡ğ‘–ğ‘ ğ‘œ,ğ‘– ) âˆ«ğ‘¡
ğ‘Š(ğœ âˆ’ ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ ,ğ‘– ) ğ‘‘ğœ
(1)

17

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

ï‚·

ï‚·

ï‚·

where ğ‘Š is the PDF of the Weibull distribution shown in Table S1, ğ‘…ğ‘– is individual ğ‘–â€™s
reproduction number, ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’,ğ‘– is the time individual ğ‘– was traced (if applicable), ğ‘‡ğ‘–ğ‘ ğ‘œ,ğ‘– is the time
individual ğ‘– was isolated (if applicable), and ğ¹(ğ‘¡) is a function describing the reduction in
infectiousness due to isolation:
1
ğ‘¡ < ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’
ğ¹(ğ‘¡, ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’ ,ğ‘‡ğ‘–ğ‘ ğ‘œ ) = {ğ‘ğ‘ğ‘¢ğ‘ğ‘Ÿ ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’ â‰¤ ğ‘¡ < ğ‘‡ğ‘–ğ‘ ğ‘œ
(2)
ğ‘ğ‘–ğ‘ ğ‘œ
ğ‘¡ â‰¥ ğ‘‡ğ‘–ğ‘ ğ‘œ
The contact matrix Î› gives the probability Î›ğ‘–ğ‘— that a secondary infection originating from group
ğ‘– will be in group ğ‘—, with âˆ‘ğ‘— Î›ğ‘–ğ‘— = 1. New infections from group ğ‘– are distributed across groups
according to these probabilities.
The contact matrix assumes 50% of contacts are from the same age group. The remaining 50%
are distributed across all three age groups in proportion to their relative size in the population,
consistent with 32 .
The model was initialised with 10 seed cases infected at time ğ‘¡ = 0. ğ‘…ğ‘’ğ‘“ğ‘“ was calculated for
each scenario using individuals who had experienced a full infectious period within 50 days of
the seed cases.

Performance indicators. For each combination of parameter values investigated, we calculated the values
of the four following performance indicators:
1. Proportion of cases quarantined or isolated within 4 days of symptom onset in the index case.
2. Proportion of cases quarantined or isolated within 4 days of quarantine or isolation of the index
case.
3. Proportion of cases with symptom onset within 4 days of symptom onset in the index case (i.e.
serial interval less than 4 days).
4. Proportion of cases quarantined before symptom onset.
Time of quarantine or isolation means time of quarantine if there was a period of pre -symptomatic
quarantine, or time of isolation otherwise. This is distinct from the time of diagnosis which may occur later
for traced cases. These indicators were calculated in the model for all clinical cases (i.e. those that
eventually became symptomatic), all of whom have an onset time and an isolation time. Asymptomatic
cases were not included in the metrics, despite being possible for some cases, as these are unlikely to be
available in collected data. This includes cases who were not traced before symptom onset, and whose
isolation date is therefore after their onset date. Indicators 1-3 additionally require the index case to be
clinical. Values of these indicators were averaged over 1000 simulations for each combination of
parameter values investigated.

Empirical calculation of performance indicators. We used the New Zealand EpiSurv dataset, centrally
managed by ESR on behalf of the Ministry of Health (accessed 2 June 2020). We included the ğ‘ = 95
cases with no recent history of overseas travel and with a symptom onset date between 8 April and 8
May. Case discovery is categorised as either â€œcontact of a caseâ€ (ğ‘ = 82), â€œsought healthcareâ€ (ğ‘ = 9)
or other (ğ‘ = 4). Of the 82 cases labelled as â€œcontact of a caseâ€, all were associated with at least one
index case, allowing the values of the first three performance indicators defined above to be empirically
calculated. For cases with multiple potential index cases, we calculated the following quantities
18

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

ï‚·
ï‚·
ï‚·
ï‚·

âˆ’
Earliest time of onset in a potential index case ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡
.
+
Latest time of onset in a potential index case ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ .
Earliest time of quarantine or isolation in a potential index case ğ‘‡ğ‘âˆ’.
Latest time of quarantine or isolation in a potential index case ğ‘‡ğ‘+.

+
âˆ’
Using ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡
and ğ‘‡ğ‘+ for all cases gave a minimum value for indicators 1-3. Using ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡
and ğ‘‡ğ‘âˆ’ for all
cases gave a maximum value for indicators 1-3. These minimum and maximum values corresponds to the
two vertical dashed lines in Fig. 3A-C. Indicator 4 does not depend on the index case, so there is a unique
value for this indicator (single vertical dashed line in Fig. 3D) which was calculated from all available case
data.

Figure S1. Distribution of generation times (time from infection of the index case to infection of secondary
cases) with no contact tracing or case isolation. Three published generation time distributions are shown
for comparison 2,28,29 .

19

medRxiv preprint doi: https://doi.org/10.1101/2020.06.10.20125013; this version posted August 7, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Parameter
Distribution of exposure to onset (days)

Value
ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ ~ Î“(ğ‘ â„ğ‘ğ‘ğ‘’ = 5.8, ğ‘ ğ‘ğ‘ğ‘™ğ‘’ = 0.95)

Distribution of generation times (days)

ğ‘‡ğ‘  âˆ’ ğ‘‡ğ‘œğ‘›ğ‘ ğ‘’ğ‘¡ + ğ‘¡ğ‘

Distribution of onset to testing (untraced
contacts) (days)
Distribution of onset to isolation (days)

~ ğ‘Šğ‘’ğ‘–ğ‘ğ‘¢ğ‘™ğ‘™(ğ‘ â„ğ‘ğ‘ğ‘’ = 2.83, ğ‘ ğ‘ğ‘ğ‘™ğ‘’ = 5.67)
ğ‘‡ğ‘¡ğ‘’ğ‘ ğ‘¡ ~Î“(ğ‘ â„ğ‘ğ‘ğ‘’ = 1.22, ğ‘ ğ‘ğ‘ğ‘™ğ‘’ = 2.17)
ğ‘‡ğ‘–ğ‘ ğ‘œ ~Î“(shape = 0.62, scale = 3.47)
ğ‘‡ğ‘Ÿğ‘’ğ‘ ğ‘¢ğ‘™ğ‘¡ âˆ’ 0.5 ~ ğ¸ğ‘¥ğ‘(0.5)

Distribution of testing to test result (days)
Distribution of test result to contact tracing
(days)
Proportion of secondary infections occurring
before symptom onset (in the absence of casetargeted control)
Relative infectiousness after quarantine

Ì…Ì…Ì…Ì…Ì…Ì…Ì…Ì…
ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’
, ğ‘ ğ‘ğ‘ğ‘™ğ‘’ = 0.1)
0.1
= 35%

ğ‘‡ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’ ~ Î“(ğ‘ â„ğ‘ğ‘ğ‘’ =
ğ‘ğ‘ğ‘Ÿğ‘’

ğ‘ğ‘ğ‘¢ğ‘ğ‘Ÿ
ğ‘ğ‘–ğ‘ ğ‘œ

Relative infectiousness after full isolation

ğ‘ğ‘¡ğ‘Ÿğ‘ğ‘ğ‘’

Proportion of contacts traced

Source
33
2

NZ Case
data
NZ Case
data
NZ Case
data
See scenario
parameters
7

See scenario
parameters
See scenario
parameters
See scenario
parameters

Age-structured scenario parameters
children (0-19 years), adults (19-65 years), elderly (over 65)
Reproduction number for clinical infections
ğ‘…ğ‘ğ‘™ğ‘–ğ‘› = 4.6, 3, 1.3
Estimated
(no case isolation or control)
from
ageadjusted
contact rates
34

ğ‘… ğºğ‘ ğ‘¢ğ‘/ğ‘… ğºğ‘ğ‘™ğ‘–ğ‘› =

Relative infectiousness of subclinical cases

50%
ğ‘ğ‘ ğ‘¢ğ‘ = 0.8, 0.33, 0.2
0.6 0.325 0.075
Î› = 0.1 0.825 0.075
0.1 0.325 0.575

Proportion of subclinical infections
Contact probabilities between groups

Table S1. The parameters used in the model and their source.

20

30 25
30
15,32

